Great information, I think like some have said if this news was while we were listed with a more biotech savvy audience on the NASDAQ it would be very well received.
I expect when they started looking into a dual listing on the NASDAQ when the potential investors in biotech in the US asked the question about money CC said she will give it away for nothing.